Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.

Loftus LT, Gala R, Yang T, Jessick VJ, Ashley MD, Ordonez AN, Thompson SJ, Simon RP, Meller R. Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance. Brain Res. 2009 May 26; 1272:71-80.

View in: PubMed

subject areas

Analysis of Variance
Animals
Animals, Newborn
Cells, Cultured
Cerebral Cortex
Cycloheximide
Down-Regulation
Glucose
Hyperthermia, Induced
Ischemic Preconditioning
L-Lactate Dehydrogenase
Neurons
Protein Synthesis Inhibitors
Rats
Rats, Sprague-Dawley
Small Ubiquitin-Related Modifier Proteins
Time Factors

authors with profiles

Robert Meller
Roger simon

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support